{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:37:44Z","timestamp":1791322664400,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.bjc.6601130","type":"journal-article","created":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T18:10:57Z","timestamp":1060711857000},"page":"763-773","source":"Crossref","is-referenced-by-count":47,"title":["Effect of Aplidin in acute lymphoblastic leukaemia cells"],"prefix":"10.1038","volume":"89","author":[{"given":"E","family":"Erba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gaipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Tognon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Celli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rotilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G T","family":"Faircloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"D'Incalci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,12]]},"reference":[{"key":"BF6601130_CR1","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0959-8049(01)00245-3","volume":"38","author":"B Albella","year":"2002","unstructured":"Albella B, Faircloth G, Lopez-Lazaro L, Guzman C, Jimeno J, Bueren JA (2002) In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors, comparison with the clinical results. Eur J Cancer 38: 1395\u20131404","journal-title":"Eur J Cancer"},{"key":"BF6601130_CR2","volume-title":"Proceedings 37th ASCO Annual Meeting","author":"JP Armand","year":"2001","unstructured":"Armand JP, Ady-Vago N, Faivre S, Chieze S, Baudin E, Ribrag V, Lecot F, Iglesias L, Lopez-Lazaro L, Guzman C, Jimeno J, Ducreux M, Le Chevalier T, Raymond E (2001) Phase I and pharmacokinetic study of aplidine (APL) given as a 24-hour continuous infusion every other week (q2w) in patients (pts) with solid tumor (ST) and lymphoma (NHL)[abstract]. Proceedings 37th ASCO Annual Meeting. San Francisco 12\u201315 May, Vol. 20, p 120a"},{"key":"BF6601130_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/sj.leu.2402788","volume":"17","author":"M Broggini","year":"2003","unstructured":"Broggini M, Marchini S, Galliera E, Borsotti P, Taraboletti G, Erba E, Sironi M, Giavazzi R, Jimeno J, Faircloth G, D'Incalci M (2003) Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGF-RI (flt-1) autocrine loop in human leukemic cells MOLT-4. Leukemia 17: 52\u201359","journal-title":"Leukemia"},{"key":"BF6601130_CR4","unstructured":"Broggini M, Marchini S, Galliera E, D'Incalci M, Taraboletti G, Giavazzi R, Faircloth GT, Jimeno J (2001) Aplidine-induced apoptosis in MOLT-4 cells is mediated by its ability to block VEGF secretion [abstract]. Proceedings AACR- NCI-EORTC International Conference: Molecular targets and cancer therapeutics, Miami, 22 October\u20132 November, p 79"},{"key":"BF6601130_CR5","first-page":"393","volume-title":"Childhood Leukemias","author":"D Campana","year":"1999","unstructured":"Campana D, Houghton PJ, Rivera GK (1999) Testing antileukemic drugs. In Childhood Leukemias, Ching-Hong Pui (ed) pp 393\u2013412. Cambridge"},{"key":"BF6601130_CR6","first-page":"482","volume":"7","author":"D Campana","year":"1993","unstructured":"Campana D, Manabe A, Evans WE (1993) Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 7: 482\u2013488","journal-title":"Leukemia"},{"key":"BF6601130_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0378-4347(99)00262-5","volume":"731","author":"N Celli","year":"1999","unstructured":"Celli N, Gallardo AM, Rossi C, Zucchetti M, D'Incalci M, Rotilio D (1999) Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography\u2013tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 731: 335\u2013343","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"BF6601130_CR8","unstructured":"Ciruelos Gil EM, Twelves C, Dominguez MJ, McKay H, Anthony A, Castellanos D, Bezares S, Ruiz A, Lopez-Lazaro L, Jimeno J, Celli N, Cotes-Funes H, Paz-Ares L (2002) Phase I clinical and pharmacokinetic study of the marine compound aplidine (APL) administered as a 3\u2009h infusion every 2 weeks. Proceedings 38th ASCO Annual Meeting, Orlando, 18\u201321 May, Vol. 21, p 106a"},{"key":"BF6601130_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1200\/JCO.1998.16.3.907","volume":"16","author":"R Consolini","year":"1998","unstructured":"Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D (1998) In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 16: 907\u2013913","journal-title":"J Clin Oncol"},{"key":"BF6601130_CR10","first-page":"1796","volume":"44","author":"SL Crampton","year":"1984","unstructured":"Crampton SL, Adams EG, Kuentzel SL, Li LH, Badiner G, Bhuyan BK (1984) Biochemical and cellular effects of didemnins A and B. Cancer Res 44: 1796\u20131801","journal-title":"Cancer Res"},{"key":"BF6601130_CR11","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1016\/S0021-9258(17)40692-2","volume":"269","author":"CM Crews","year":"1994","unstructured":"Crews CM, Collins JL, Lane WS, Snapper ML, Schreiber SL (1994) GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1alpha. J Biol Chem 269: 15411\u201315414","journal-title":"J Biol Chem"},{"key":"BF6601130_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bjc.1998.570","volume":"78","author":"H Depenbrock","year":"1998","unstructured":"Depenbrock H, Peter R, Faircloth GT, Manzanares I, Jimeno J, Hanauske AR (1998) In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells. Br J Cancer 78: 739\u2013744","journal-title":"Br J Cancer"},{"key":"BF6601130_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/sj.bjc.6600265","volume":"86","author":"E Erba","year":"2002","unstructured":"Erba E, Bassano L, Di Liberti G, Muradore I, Chiorino G, Ubezio P, Vignati S, Codegoni A, Desiderio MA, Faircloth G, Jimeno J, D'Incalci M (2002) Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine. Br J Cancer 86: 1510\u20131517","journal-title":"Br J Cancer"},{"key":"BF6601130_CR14","unstructured":"Faircloth G, Perez J, Fernandez JLSP, Avila J, Garcia M, Erba E, D'Incalci M, Canedo A, Garcia de Quesada T, Jimeno J (1995) Marine depsipeptides with activity against solid tumour models [abstract]. Proceedings 8th ECCO Congress, Paris, 29 October\u20132 November, p 529"},{"issue":"Suppl 1","key":"BF6601130_CR15","first-page":"34","volume":"7","author":"JG Faircloth","year":"1996","unstructured":"Faircloth JG, Rinehart K, Nunez de Castro I, Jimeno J (1996) Dehydrodidemnin B (DDB) a new marine derived antitumour agent (MDA) with activity against experimental tumour models [abstract]. Ann Oncol 7 (Suppl 1): 34","journal-title":"Ann Oncol"},{"key":"BF6601130_CR16","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1038\/sj.onc.1205972","volume":"21","author":"LF Garcia-Fernandez","year":"2002","unstructured":"Garcia-Fernandez LF, Losada A, Alcaide V, Alvarez AM, Cuadrado A, Gonzalez L, Nakayama K, Nakayama KI, Fernandez-Sousa JM, Munoz A, Sanchez-Puelles JM (2002) Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene 21: 7533\u20137544","journal-title":"Oncogene"},{"key":"BF6601130_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s002800050983","volume":"44","author":"AA Geldof","year":"1999","unstructured":"Geldof AA, Mastbergen SC, Henrar RE, Faircloth GT (1999) Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays. Cancer Chemother Pharmacol 44: 312\u2013318","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6601130_CR18","doi-asserted-by":"publisher","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation. J Biol Chem 273: 30336\u201330343","journal-title":"J Biol Chem"},{"key":"BF6601130_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0145-2126(97)00092-1","volume":"21","author":"A Gobbi","year":"1997","unstructured":"Gobbi A, Di Berardino C, Scanziani E, Garofalo A, Rivolta A, Fontana G, Rambaldi A, Giavazzi R, Biondi A (1997) A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice. Leuk Res 21: 1107\u20131114","journal-title":"Leuk Res"},{"key":"BF6601130_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1006\/bbrc.1995.2580","volume":"215","author":"DR Grubb","year":"1995","unstructured":"Grubb DR, Wolvetang EJ, Lawen A (1995) Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described. Biochem Biophys Res Comm 215: 1130\u20131136","journal-title":"Biochem Biophys Res Comm"},{"key":"BF6601130_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/10428199409059601","volume":"12","author":"T Higa","year":"1994","unstructured":"Higa T, Okabe M, Kunieda Y, Kodama S, Itaya T, Kurosawa M, Sakurada K, Maekawa I, Shoji M, Kasai M, Miyazaki T (1994) Establishment and characterization of a new Ph1-positive ALL cell line (ALL\/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr\/abl transcript: suggestion of in vitro differentiation to monocytoid lineage. Leuk Lymphoma 12: 287\u2013296","journal-title":"Leuk Lymphoma"},{"key":"BF6601130_CR22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood.V91.3.1001","volume":"91","author":"C Ito","year":"1998","unstructured":"Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D (1998) Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood 91: 1001\u20131007","journal-title":"Blood"},{"key":"BF6601130_CR23","first-page":"1116","volume":"8","author":"M Kumagai","year":"1994","unstructured":"Kumagai M, Manabe A, Coustan-Smith E, Blakley RL, Beck WT, Santana VM, Behm FG, Raimondi SC, Campana D (1994) Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia 8: 1116\u20131123","journal-title":"Leukemia"},{"key":"BF6601130_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI118474","volume":"97","author":"M Kumagai","year":"1996","unstructured":"Kumagai M, Manabe A, Pui CH, Behm FG, Raimondi SC, Hancock ML, Mahmoud H, Crist WM, Campana D (1996) Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 97: 755\u2013760","journal-title":"J Clin Invest"},{"key":"BF6601130_CR25","first-page":"333","volume":"17","author":"C Lobo","year":"1997","unstructured":"Lobo C, Garcia-Pozo SG, De Castro IN, Alonso FJ (1997) Effect of dehydrodidemnin B on human colon carcinoma cell lines. Anticancer Res 17: 333\u2013336","journal-title":"Anticancer Res"},{"key":"BF6601130_CR26","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","volume":"79","author":"A Manabe","year":"1992","unstructured":"Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D (1992) Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79: 2370\u20132377","journal-title":"Blood"},{"key":"BF6601130_CR27","first-page":"1990","volume":"7","author":"A Manabe","year":"1993","unstructured":"Manabe A, Yi T, Kumagai M, Campana D (1993) Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 7: 1990\u20131995","journal-title":"Leukemia"},{"key":"BF6601130_CR28","first-page":"241","volume":"16","author":"S Marchini","year":"2002","unstructured":"Marchini S, Chiorino G, Faircloth GT, D'Incalci M (2002) Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines. J Biol Regul Homeost Agents 16: 241\u2013248","journal-title":"J Biol Regul Homeost Agents"},{"key":"BF6601130_CR29","unstructured":"Maroun JA, Goel R, Stewart DJ, Tomiak E, Belanger K, Soulieres D, Charpentier D, Seymour L, Matthews S, Jimeno J, Guzman C (2001) Phase I study of aplidine in a 5 day bolus Q 3 weeks in patients with solid tumors and lymphomas. Proceedings 37th ASCO Annual Meeting, San Francisco, 12\u201315 May, Vol. 20, p 83b"},{"key":"BF6601130_CR30","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1103\/PhysRevE.57.5877","volume":"57","author":"F Montalenti","year":"1998","unstructured":"Montalenti F, Sena G, Cappella P, Ubezio P (1998) Simulating cancer-cell kinetics after drug treatment: application to cisplatin on ovarian carcinoma. Phys Rev E 57: 5877\u20135887","journal-title":"Phys Rev E"},{"key":"BF6601130_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0002-9440(10)65284-4","volume":"154","author":"JE Nor","year":"1999","unstructured":"Nor JE, Christensen J, Mooney DJ, Polverini PJ (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375\u2013384","journal-title":"Am J Pathol"},{"key":"BF6601130_CR32","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V69.4.990.990","volume":"69","author":"M Okabe","year":"1987","unstructured":"Okabe M, Matsushima S, Morioka M, Kobayashi M, Abe S, Sakurada K, Kakinuma M, Miyazaki T (1987) Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood 69: 990\u2013998","journal-title":"Blood"},{"key":"BF6601130_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00001622-200001000-00002","volume":"12","author":"CH Pui","year":"2000","unstructured":"Pui CH (2000) Acute lymphoblastic leukemia in children. Curr Opin Oncol 12: 3\u201312","journal-title":"Curr Opin Oncol"},{"key":"BF6601130_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","volume":"2","author":"CH Pui","year":"2001","unstructured":"Pui CH, Campana D, Evans WE (2001) Childhood acute lymphoblastic leukaemia\u2013current status and future perspectives. Lancet Oncol 2: 597\u2013607","journal-title":"Lancet Oncol"},{"key":"BF6601130_CR35","unstructured":"Raymond E, Ady-Vago N, Baudin E, Ribrag V, Faivre SLF, Wright T, Lopez Lazaro L, Guzman C, Jimeno J, Ducreux M, Chevalier T, Armand JP (2000) A phase I and pharmacokinetic study of aplidine (APL) given as a 24-hour continuous infusion every other week (q2w) in patients (pts) with solid tumor (ST) and lymphoma (NHL) [abstract]. Proceedings 11th NCI-EORTC-AACR Symposium, Amsterdam, 7\u201310 November, p 86"},{"key":"BF6601130_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/267841a0","volume":"267","author":"C Rosenfeld","year":"1977","unstructured":"Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL, Greaves MF (1977) Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 267: 841\u2013843","journal-title":"Nature"},{"key":"BF6601130_CR37","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1021\/jm960048g","volume":"39","author":"R Sakai","year":"1996","unstructured":"Sakai R, Rinehart KL, Kishore V, Kundu B, Faircloth G, Gloer JB, Carney JR, Namikoshi M, Sun F, Hughes Jr RG, Gravalos DG, De Quesada TG, Wilson GR, Heid RM (1996) Structure\u2013activity relationships of the didemnins. J Med Chem 39: 2819\u20132834","journal-title":"J Med Chem"},{"key":"BF6601130_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0304-3835(96)04151-1","volume":"102","author":"JL Urdiales","year":"1996","unstructured":"Urdiales JL, Morata P, Nunez de Castro I, Sanchez-Jimenez F (1996) Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett 102: 31\u201337","journal-title":"Cancer Lett"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:23Z","timestamp":1684414283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF6601130"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601130","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}